WeChat Mini Program
Old Version Features

Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.

Gupta Nidhi,Gupta Dharna,Dixit Jyoti,Mehra Nikita,Singh Ashish,Krishnamurthy Manjunath Nookala,Jyani Gaurav,Rajsekhar Kavitha,Kalaiyarasi Jayachandran Perumal,Roy Partha Sarathi,Malik Prabhat Singh,Mathew Anisha,Malhotra Pankaj,Gupta Sudeep,Kumar Lalit,Kataki Amal,Prinja Shankar

Applied health economics and health policy（2022）

Cited 7|Views20
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined